Picture of PAION AG logo

PA8 — PAION AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Paion End-Sept Cash And Cash Equivalents At EUR 22.8 Million

Nov 6 (Reuters) - PAION AG  PA8G.DE :
    * PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST NINE
MONTHS OF
2019
    * CASH AND CASH EQUIVALENTS OF EUR 22.8 MILLION AS OF 30
SEPTEMBER
2019
    * NDA FOR REMIMAZOLAM ACCEPTED FOR REVIEW BY FDA - PDUFA
DATE SET
FOR 05 APRIL 2020

Source text for Eikon:  ID:nEQbgLvf3a 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on PAION AG

See all news